By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > Jeff Smith, the activist picking a fight with Covid hero Pfizer
News

Jeff Smith, the activist picking a fight with Covid hero Pfizer

News Room
Last updated: 2024/10/25 at 2:23 PM
By News Room
Share
9 Min Read
SHARE

Taking to the stage this week in front of an annual gathering of activist investors at New York’s Pierre Hotel, Starboard Value chief executive Jeff Smith was in a hurry to explain his latest bold bet.

After speeding through the hedge fund’s plans for software giant Salesforce and consumer drugmaker Kenvue, Smith flicked to a slide of the double-helix logo of one of America’s most venerable pharmaceutical companies.

“Anybody want to talk about Pfizer?” the 52-year-old asked with a wry smile.

Smith’s presentation to about 400 investors at the 13D Active-Passive conference was meant to be the first Wall Street had heard of Starboard’s $1bn stake in the New York-based drugmaker. But a series of seemingly misfired emails from former Pfizer finance chief Frank D’Amelio, who briefly collaborated with Starboard, had put the company on alert.

The activist investor’s call for a shake-up of Pfizer was initially backed by D’Amelio and ex-CEO Ian Read but within 72 hours the pair had fallen back into line, coming out in support of Pfizer’s chief executive Albert Bourla. Starboard accused Pfizer of foul play.

Pfizer ranks among Starboard’s biggest and most daring gambles © Alberto Ruiz/Europa Press via Getty Images

Smith expressed gratitude to Bourla at the conference for delivering a Covid-19 vaccine that had restored normality, before calmly outlining how Pfizer under his leadership had destroyed at least $20bn in value through a series of misguided acquisitions and research and development bets.

Calling on the 14-person board to “hold management accountable”, he warned: “They can’t follow Einstein’s definition of insanity and continue to do the same thing over and over again and expect a different result.”

Pfizer ranks among Starboard’s biggest and most daring gambles — not least because there are few quick cures for the pharma group’s ills. The $8bn hedge fund’s highest-profile skirmish in the sector, when it took a stake in Bristol Myers Squibb before opposing its $74bn acquisition of Celgene, came to little but still turned a profit for the fund.

An adviser who worked with BMS said Smith’s case against Pfizer — outlined in a 74-page deck — was “far better prosecuted” than its opposition to the Celgene takeover. “I don’t think he’s this guy on a crusade to make Pfizer a better company . . . he has a position in the stock and he wants to make money,” they added.

Smith and Starboard did not respond to requests for comment. Pfizer declined to comment.

Smith has become the face of one of the more divisive corners of finance. The top 50 activist hedge funds controlled more than $156bn in assets by the end of last year, with activists holding stakes in nearly a fifth of S&P 500 companies, yet companies in the sector have a habit of creating enemies of scorned chief executives and board members following bruising proxy fights.

An Olive Garden restaurant in Fremont, California
In a 2014 campaign against Darden Restaurants, Jeff Smith replaced all 12 board members in a proxy fight © David Paul Morris/Bloomberg

A native of New York’s Long Island, Smith, whose father was a businessman and mother was a real estate broker, had envisioned from a young age a future as an entrepreneur. After graduating from Wharton Business School, he kicked off his career as a Société Générale investment banker but was quickly summoned home to help with a dilemma affecting his father’s company.

Fresh Juice Co was bogged down in a boardroom dispute after acquiring a series of competitors that were granted board seats. To ease the stress on his father, Smith, then 26, engineered a sale to the Saratoga Beverage Group for about $20mn.

He launched Starboard in 2011 alongside two partners, spinning it out of an investment group previously owned by SocGen. Starboard has since targeted 153 companies, including Yahoo, AOL and News Corp, and several other of the biggest names in corporate America.

Smith has served on or advised 17 company boards, chairing four of them. In a seminal 2014 campaign against Darden Restaurants, laid out in a 294-page deck that criticised its Italian dining chain Olive Garden for overspending on breadsticks and for no longer salting its pasta water to extend the warranty on its pots, the activist investor replaced all 12 board members in a proxy fight, a feat never repeated at a Fortune 500 company.

Starboard’s ruthlessness earned Smith the moniker “the most feared man in corporate America” in a 2014 Forbes article but many of the executives who served under him said he had a more deft touch. One of his other early campaigns was against biotech Surmodics.

Ian Read, chief executive officer of Pfizer, center, and Frank D’Amelio, chief financial officer of Pfizer, center right
Losing the support of Ian Read, centre, and Frank D’Amelio, centre right, two former Pfizer executives, has weakened Starboard’s campaign against the company © Simon Dawson/Bloomberg

“Everybody’s fearful of activists because they just don’t understand them,” said Gene Lee, who Smith promoted to Darden chief executive. Lee said Smith was open-minded to how Darden “wasn’t quite as broken as he thought”, and was instrumental to “right[ing] the ship quickly”.

Smith’s playbook is a long way from the more public and hostile crusades waged by other activist investors Carl Icahn and Bill Ackman.

Far from being glued to a Bloomberg terminal, his due diligence on a business is done on the shop floor. After becoming Darden’s chair, he and fellow board members did shifts at Olive Garden restaurants to study the business up close. At outlets of Papa Johns, another company he chaired, Smith learnt how to make pizza.

Marc Benioff, founder and chief executive of Salesforce, fostered an unexpected bond with Smith after Starboard became the first of six activist investors on its shareholder register.

“He’s very sweet, he’s very casual and he’s very insightful,” said Benioff. “I would not mind being an activist myself . . . I wish I had met [Smith] years before, it would have made the business even stronger.”

Similarly, Smith’s respect for D’Amelio grew when they worked across the table from one another when Starboard waged a campaign against health insurer Humana, where the former Pfizer executive was a board member. That led Smith to call D’Amelio when he was considering an investment in Pfizer. D’Amelio then recruited Read.

Losing the support of the two former executives has weakened Starboard’s campaign against Pfizer, but not terminally. Shares in Pfizer jumped 5.6 per cent in the days after Starboard’s stake was revealed but those gains have since evaporated. Pfizer’s market value stood at $162bn on Friday morning, more than 50 per cent down on its pandemic peak.

One executive who fell out with Smith during one of Starboard’s proxy fights said they hoped Bourla would triumph against the hedge fund boss, who was “beneath him in terms of a business stature”, if a proxy fight were to break out.

But another possibility is that Bourla, who met Smith for the first time last week at Pfizer’s New York headquarters, becomes his latest unlikely collaborator.

Read the full article here

News Room October 25, 2024 October 25, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Push by private equity and Big Four into law sparks California backlash

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Canadian Ministers Joly, LeBlanc and Francois-Phillippe Champagne make an announcement

Watch full video on YouTube

How U.S. Supply Chains Are Under Attack By Cargo Theft Criminals | Full Documentary

Watch full video on YouTube

Lyft-ing Off: Solid Growth Makes It A Buy, But Uber Is The Better Long-Term Bet

This article was written byFollowI have been investing in the stock market…

New pope breaks with Francis to support Kyiv and ceasefire push

Stay informed with free updatesSimply sign up to the War in Ukraine…

- Advertisement -
Ad imageAd image

You Might Also Like

News

Push by private equity and Big Four into law sparks California backlash

By News Room
News

Lyft-ing Off: Solid Growth Makes It A Buy, But Uber Is The Better Long-Term Bet

By News Room
News

New pope breaks with Francis to support Kyiv and ceasefire push

By News Room
News

US retreats from full-scale trade war with China

By News Room
News

Trump and the art of the international peace deal

By News Room
News

China and US agree to slash tariffs

By News Room
News

Kurdish militant group PKK says it will disband and end Turkey conflict

By News Room
News

The EU needs a new geopolitical compass

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?